Greffex, Inc. Email Format

Biotechnology ResearchColorado, United States2-10 Employees

Greffex, Inc. is a privately held biotechnology research company headquartered in Aurora, Colorado, established in 1999. It focuses on novel genetic platforms for the development and production of vaccines, with its GREVAX universal platform designed to enable faster, more affordable vaccine development and manufacturing. The company states that once a pathogen is identified, its team can design and produce a GREVAX vaccine in as little as four weeks, positioning its technology as a flexible delivery vehicle for a range of infectious diseases. Greffex operates on a global scale with a small team and has pursued partnerships to expand its manufacturing capabilities in the United States, as evidenced by a collaboration announced with FUJIFILM Diosynth Biotechnologies. The company sits within the biotechnology research sector, aiming to address public health challenges by accelerating vaccine development for illnesses including pandemic influenza, anthrax, dengue, malaria, hepatitis C, RSV, Ebola, HPV, plague, tuberculosis, and other candidates.

Get verified Greffex, Inc. emails free

Company overview Employee directory